BF
ANVS icon

BOK Financial’s Annovis Bio ANVS Stock Holding History

BOK Financial’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Hold
555
– – ﹤0.01% 1109
2026
Q1 		$1.24K Buy
+555
New +$1.52K ﹤0.01% 1017
2025
Q4 		– Sell
-555
Closed -$1.15K – 1010
2025
Q3 		$1.15K Hold
555
– – ﹤0.01% 1074
2025
Q2 		$1.2K Hold
555
– – ﹤0.01% 1071
2025
Q1 		$833 Hold
555
– – ﹤0.01% 1191
2024
Q4 		$2.71K Hold
555
– – ﹤0.01% 1109
2024
Q3 		$4.45K Buy
+555
New +$5.2K ﹤0.01% 1075

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BOK Financial's ANVS Position: Q2 2026 in Review

BOK Financial held its Annovis Bio (ANVS) position steady in Q2 2026 at 555 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

BOK Financial first reported a position in ANVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.45K in Q3 2024. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • BOK Financial held 555 shares of Annovis Bio worth $1.03K as of Q2 2026.
  • BOK Financial left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #1109 holding.
  • BOK Financial first reported a position in Annovis Bio in Q3 2024 and has held it in 7 quarters since.
  • BOK Financial's Annovis Bio position peaked at $4.45K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.